These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 30175478)

  • 1. Digital era drug surveillance: Quo vadis, Australia?
    Raubenheimer JE; Barratt MJ
    Drug Alcohol Rev; 2018 Sep; 37(6):693-696. PubMed ID: 30175478
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticlopidine: quo vadis? Adverse reactions in man.
    Goyan JE
    Agents Actions Suppl; 1984; 15():116-25. PubMed ID: 6592942
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence of false-positive results in a commercially available rotavirus assay in the vaccine era, Australia, 2011 to 2012.
    Ye S; Roczo-Farkas S; Whiley D; Lambert S; Robson J; Heney C; Nimmo G; Grimwood K; Sloots T; Kirkwood C
    Euro Surveill; 2013 May; 18(21):. PubMed ID: 23725979
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-marketing surveillance of drugs.
    Bell KD
    Med J Aust; 1991 Apr; 154(8):567. PubMed ID: 2064665
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug regulation in Australia.
    Med J Aust; 1990 Jan; 152(1):53-4. PubMed ID: 2294381
    [No Abstract]   [Full Text] [Related]  

  • 6. Analyses of liquid diazinon formulations and breakdown products: an Australia-wide survey.
    Allender WJ; Britt AG
    Bull Environ Contam Toxicol; 1994 Dec; 53(6):902-6. PubMed ID: 7881220
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug regulation in Australia.
    Hall RC
    Med J Aust; 1989 Sep; 151(6):338-40, 343-6. PubMed ID: 2687666
    [No Abstract]   [Full Text] [Related]  

  • 8. HPV related surveillance activities in Australia.
    Brotherton J; Kaldor JM; McIntyre P
    Vaccine; 2010 Nov; 28(47):7453-4. PubMed ID: 20854898
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous active surveillance of adverse events following immunisation using SMS technology.
    Westphal DW; Williams SA; Leeb A; Effler PV
    Vaccine; 2016 Jun; 34(29):3350-5. PubMed ID: 27206385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post marketing surveillance of new drugs. Patient safety in the hands of GPs.
    Marley JE
    Aust Fam Physician; 1989 Sep; 18(9):1133-5. PubMed ID: 2590077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-bone marrow interactions.
    Berbatis CG; Hurley SF
    Med J Aust; 1987 Jul; 147(2):101. PubMed ID: 3600446
    [No Abstract]   [Full Text] [Related]  

  • 12. Promoting and advertising therapeutic goods. Trade Practices Commission report on self-regulation.
    Moulds RF
    Med J Aust; 1992 Oct; 157(8):513-4. PubMed ID: 1479969
    [No Abstract]   [Full Text] [Related]  

  • 13. Australian and New Zealand governments agree to proceed with the joint regulatory agency for therapeutic products.
    Moore J
    J Law Med; 2011 Dec; 19(2):272-4. PubMed ID: 22320002
    [No Abstract]   [Full Text] [Related]  

  • 14. [Postmarketing surveillance studies in community pharmacies].
    Nieber K; Lehmacher W
    Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia.
    Harrison-Woolrych M; Hill R
    Contraception; 2005 Apr; 71(4):306-8. PubMed ID: 15792651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-marketing drug safety in the era of genomic medicine.
    Zavras AI
    J Dent Res; 2005 Feb; 84(2):105-6. PubMed ID: 15668326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tolerance and safety of tramadol use. Results of international studies and data from drug surveillance].
    Cossmann M; Kohnen C; Langford R; McCartney C
    Drugs; 1997; 53 Suppl 2():50-62. PubMed ID: 9190325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing surveillance-one of the key issues in drug development.
    Székely G; Görgényi F
    Ther Hung; 1992; 40(4):147-53. PubMed ID: 1345020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing surveillance study of a non-chlorofluorocarbon inhaler Postmarketing surveillance studies remain unethical.
    Patterson C
    BMJ; 1999 Mar; 318(7186):810-11. PubMed ID: 10215393
    [No Abstract]   [Full Text] [Related]  

  • 20. [The need for 'postmarketing surveillance'].
    Stricker BH; in 't Veld BA; Feenstra J
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):711-3. PubMed ID: 10347624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.